Total hip arthroplasty for Crowe IV hip without subtrochanteric shortening osteotomy -a long term follow up study

Kawai, Toshiyuki; Tanaka, Chiaki; Kanoe, Hiroshi

doi:10.1186/1471-2474-15-72

Cited by 32 publications

(28 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The postoperative JOA score was favorable without any significant difference between the H and control group, and between the FO and N-FO group. The JOA score in patients with high hip dislocation was not much different from previous reports [Kawai T et al, 2014]. Although no significant difference was detected, the JOA score tended to be poor in the cases with femoral osteotomy (FO group).…”

Section: Promscontrasting

confidence: 69%

Patient-reported outcomes following primary total hip arthroplasty in Crowe type Ⅲ or Ⅳ developmental dysplasia are comparable to those in Crowe type Ⅰ: a case-control study of 96 hips with intermediate-term follow-up

Ueoka

Kabata

Kajino

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: A few previous studies have investigated patient satisfaction following total hip arthroplasty (THA) according to the degree of pelvic deformity. This study compared patient-reported outcomes following primary THA for Crowe types Ⅲ, Ⅳ and I dysplasia.Methods: This was the retrospective case-control study assessed patients who underwent primary THA by a single surgeon at a single institution from 2008 to 2016. We sent postal questionnaires to 38 patients with Crowe type III and IV dysplasia. Among the questionnaire respondents, 23 patients, excluding cases with a follow-up period of less than 1 year, were enrolled as the H group. The control group included 46 patients with Crowe type I, matched for sex, age, body mass index and surgical approach. To investigate the influence of femoral shortening osteotomy, the H group was divided according to whether or not femoral shortening osteotomy was performed. Ten patients underwent THA with femoral shortening osteotomy (FO group), while 12 patients underwent THA without femoral shortening osteotomy (N-FO group). Patient demographics, average follow-up period, surgical information, pre- and postoperative leg length discrepancy (LLD), and perioperative complications were investigated. Clinical evaluations were performed using the Japanese Orthopaedic Association (JOA) scores, 36-item short-form survey (SF-36), net promotor score (NPS), visual analogue scale (VAS), and questionnaires. The VAS and SF-36 was acquired at only final follow-up. Results: The H and control groups were not significantly different in the postoperative JOA scores and SF-36. In the H group, VAS at the final follow-up was significantly higher, and significantly more patients felt that postoperative rehabilitation was serious, expressing that they underwent THA for LLD correction. Additionally, VAS in the FO group was higher than those in the N-FO group. Postoperative LLD was significantly greater in the H group than in the control group. Each group had the NPS of over 50.Conclusion: The postoperative VAS was higher in Crowe type Ⅲ and Ⅳ dysplasia than in Crowe type I dysplasia, but there were no significant differences in the postoperative satisfaction, JOA score and SF-36. The findings may help explain the effects of THA preoperatively to patients with Crowe type Ⅲ and Ⅳ dysplasia.Level of Evidence: Therapeutic Level 3b

show abstract

Section: Promscontrasting

confidence: 69%

Patient-reported outcomes following primary total hip arthroplasty in Crowe type Ⅲ or Ⅳ developmental dysplasia are comparable to those in Crowe type Ⅰ: a case-control study of 96 hips with intermediate-term follow-up

Ueoka

Kabata

Kajino

et al. 2020

Preprint

View full text Add to dashboard Cite

show abstract

“…The postoperative JOA score was favorable without any signi cant difference between the H and control groups, and between the FO and N-FO groups. The JOA score in the patients with high hip dislocation was not much different from those in previous reports [Kawai T et al, 2014]. Although no signi cant difference was detected, the JOA score tended to be poor in the cases with femoral osteotomy (FO group).…”

Section: Promscontrasting

confidence: 60%

Patient-reported outcomes following primary total hip arthroplasty in Crowe type Ⅲ or Ⅳ developmental dysplasia are comparable to those in Crowe type Ⅰ: a case-control study of 96 hips with intermediate-term follow-up

Ueoka

Kabata

Kajino

et al. 2020

Preprint

View full text Add to dashboard Cite

Background: A few previous studies have investigated patient satisfaction after total hip arthroplasty (THA) according to the degree of pelvic deformity. This study compared patient-reported outcomes after primary THA for Crowe types Ⅲ, Ⅳ and I dysplasia.Methods: This retrospective, single-center, single-surgeon case-control study included patients who underwent primary THA between 2008 and 2016. We sent postal questionnaires to 38 patients with Crowe type III and IV dysplasia. Among the questionnaire respondents, 23 patients, excluding those with a follow-up period of < 1 year, were enrolled as the H group. The control group included 46 patients with Crowe type I, matched for sex, age, body mass index and surgical approach. To investigate the influence of femoral shortening osteotomy, the H group was divided according to whether femoral shortening osteotomy was performed. Ten patients underwent THA with femoral shortening osteotomy (FO group), while 12 patients underwent THA without femoral shortening osteotomy (N-FO group). Patient demographics, mean follow-up period, surgical information, pre- and postoperative leg length discrepancy (LLD), and perioperative complications were investigated. Clinical evaluations were performed using the Japanese Orthopaedic Association (JOA) scores, 36-item short-form survey (SF-36), net promotor score (NPS), visual analogue scale (VAS), and questionnaires. The VAS and SF-36 scores were determined only at final follow-up.Results: The H and control groups were not significantly different in the postoperative JOA scores and SF-36. In the H group, VAS at the final follow-up was significantly higher, and significantly more patients felt that postoperative rehabilitation was serious, expressing that they underwent THA for LLD correction. In addition, the VAS scores in the FO group was higher than those in the N-FO group. Postoperative LLD was significantly greater in the H group than in the control group. Each group had an NPS of >50.Conclusion: The postoperative VAS score was higher in Crowe type Ⅲ and Ⅳ dysplasia than in Crowe type I dysplasia, but no significant differences were detected in the postoperative satisfaction, JOA score, and SF-36 score. These findings may help explain the effects of THA preoperatively to patients with Crowe type Ⅲ and Ⅳ dysplasia.Level of Evidence: Therapeutic Level 3b

show abstract

“…There were 12 men (12 hips, 19.3%) and 46 women (48 hips, 80.7%) with a mean age of 41.3 (range 16-69) years. The mean body mass index was 22.9 kg/ m 2 (range 15.8-35.1), and the mean duration of follow-up was 12.3 years (range [5][6][7][8][9][10][11][12][13][14][15][16][17][18][19][20][21][22].…”

Section: Patient Cohortmentioning

confidence: 99%

“…All radiographic measurements were analyzed twice, each by 2 investigators who had not participated in the index surgery. Preoperative LLD was calculated using the height difference of the lines crossing the prominent points of LT and parallel to the lines passing the lowest points of the teardrop [19]. When the deformation of LT was too severe, the tip of the greater trochanter was used as the reference [26].…”

Section: Radiographic Measurementsmentioning

confidence: 99%

Total Hip Arthroplasty With Subtrochanteric Shortening Osteotomy in Patients With High Hip Dislocation Secondary to Childhood Septic Arthritis: A Matched Comparative Study With Crowe IV Developmental Dysplasia

Park

Lim

Cha

et al. 2020

The Journal of Arthroplasty

View full text Add to dashboard Cite

Total hip arthroplasty for Crowe IV hip without subtrochanteric shortening osteotomy -a long term follow up study

Cited by 32 publications

References 22 publications

Patient-reported outcomes following primary total hip arthroplasty in Crowe type Ⅲ or Ⅳ developmental dysplasia are comparable to those in Crowe type Ⅰ: a case-control study of 96 hips with intermediate-term follow-up

Patient-reported outcomes following primary total hip arthroplasty in Crowe type Ⅲ or Ⅳ developmental dysplasia are comparable to those in Crowe type Ⅰ: a case-control study of 96 hips with intermediate-term follow-up

Patient-reported outcomes following primary total hip arthroplasty in Crowe type Ⅲ or Ⅳ developmental dysplasia are comparable to those in Crowe type Ⅰ: a case-control study of 96 hips with intermediate-term follow-up

Total Hip Arthroplasty With Subtrochanteric Shortening Osteotomy in Patients With High Hip Dislocation Secondary to Childhood Septic Arthritis: A Matched Comparative Study With Crowe IV Developmental Dysplasia

Contact Info

Product

Resources

About